Physician profile
Ashley R Torres
NPI 1467918516
$942.01
in general payments reported to CMS, 2019-2025
11 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $75.18 · 2024: $309 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.07 |
| Education | $182.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $330.73 | 2021-2025 | Ninlaro |
| Janssen Biotech, INC. | $297.73 | 2024-2025 | Darzalex, Tecvayli, Talvey |
| Astrazeneca Pharmaceuticals LP | $113.27 | 2024-2025 | Calquence |
| Merck Sharp & Dohme LLC | $53.86 | 2024-2025 | Keytruda, Prevymis, Lynparza |
| Celgene Corporation | $30.35 | 2022 | |
| Adaptive Biotechnologies Corporation | $27.90 | 2022 | |
| Glaxosmithkline, LLC. | $20.77 | 2025 | Blenrep |
| Genzyme Corporation | $17.50 | 2025 | |
| Legend Biotech USA INC. | $16.93 | 2022 | |
| Smith+Nephew, INC. | $16.66 | 2025 | Collagenase Santyl |
| Genmab U.S., INC. | $16.31 | 2025 | Epkinly |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.